CEDARS-SINAI MEDICAL CENTER Los Angeles (June 8, 2021) — IBDs, including Crohn’s disease and ulcerative colitis, are chronic conditions that occur when the intestinal immune system becomes overreactive, causing chronic diarrhea and other digestive symptoms. In a published survey at the beginning of COVID-19 vaccine distribution, 70% of IBD patients reported concern about side effects...
Tag: <span>COVID-19 vaccines</span>
Post
Researchers identify potential new targets for next-generation COVID-19 vaccines
by Allessandra Dicorato, Broad Institute of MIT and Harvard Credit: Susanna Hamilton, Broad Communications Peptides encoded by unexplored regions of the SARS-CoV-2 genome provoke strong immune responses compared to other known peptides. Current COVID-19 vaccines are effective at preventing severe disease, including infection caused by known variants of concern. But new variants of the SARS-CoV-2 virus...
Post
CDC reports more allergic reactions to Covid-19 vaccines, but cases remain few
By HELEN BRANSWELL @HelenBranswell A pharmacist prepares to administer the Covid-19 vaccine developed by Pfizer and its partner BioNTech. JOSEPH PREZIOSO/AFP VIA GETTY IMAGES Twenty-nine people in the United States have developed anaphylaxis after being vaccinated against Covid-19 since the vaccine rollout began, health officials reported Wednesday, with cases occurring after vaccination using both the Pfizer-BioNTech and...
Post
Allergists offer reassurance regarding potential allergic reactions to COVID-19 vaccines
MASSACHUSETTS GENERAL HOSPITAL BOSTON – Reports of possible allergic reactions to the COVID-19 vaccines produced by Pfizer-BioNTech and Moderna, both recently approved for emergency use by the U.S. Food and Drug Administration (FDA), have raised public concern. A team of experts led by allergists at Massachusetts General Hospital (MGH) has now examined all relevant information...
Post
With strong data on two Covid-19 vaccines, we have more answers about the road ahead — and questions too
By ADAM FEUERSTEIN, DAMIAN GARDE and ANDREW JOSEPH The success of a second vaccine against Covid-19 means the world is a big step closer to curbing the coronavirus pandemic. Moderna, joined by U.S. government scientists, announced Monday that their mRNA vaccine candidate was 94.5% effective in preventing Covid-19, the disease caused by the novel coronavirus, according to...
Post
Surrogate coronavirus may help researchers discover therapies and vaccines
by Albert Einstein College of Medicine To study the potentially lethal coronavirus, Albert Einstein College of Medicine scientists have turned a relatively harmless virus into a coronavirus “surrogate” that is much safer to work with. The research was described this month in Cell Host & Microbe. “Research on the ‘real’ coronavirus is limited by the...
Post
Scientists are experimenting with three kinds of COVID-19 vaccines
It can take years to develop a time-tested vaccine. But the world needs something faster. By Jean Peccoud Injected vaccines can work in many different ways. Some might edit your DNA; some might use a harmless vaccine as cover.Igor Vetushko/Deposit Photos Jean Peccoud is a professor and Abell Chair in synthetic biology at Colorado State...